News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
483,656 Results
Type
Article (8017)
Company Profile (140)
Press Release (475499)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166754)
Career Advice (305)
Deals (25739)
Drug Delivery (7)
Drug Development (52884)
Employer Resources (14)
FDA (9761)
Job Trends (8575)
News (238214)
Policy (17912)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (484)
Accelerated approval (21)
ADA (18)
Adcomms (1)
Allergies (94)
Alliances (33158)
ALS (103)
Alzheimer's disease (972)
Antibody-drug conjugate (ADC) (258)
Approvals (10355)
Artificial intelligence (315)
ASCO (159)
Autoimmune disease (204)
Automation (28)
Bankruptcy (262)
Best Places to Work (6959)
BIO (36)
BIOSECURE Act (1)
Biosimilars (107)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (135)
Brain cancer (28)
Breast cancer (503)
Cancer (3597)
Cardiovascular disease (215)
Career advice (245)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (473)
Cervical cancer (34)
Clinical research (47798)
Collaboration (1222)
Commercialization (2)
Compensation (1412)
Complete response letters (34)
COVID-19 (755)
CRISPR (63)
C-suite (725)
Cystic fibrosis (84)
Data (5560)
Denatured (4)
Depression (102)
Dermatology (60)
Diabetes (337)
Diagnostics (4169)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (149)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (161)
Earnings (73216)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87523)
Executive appointments (689)
FDA (12329)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (17)
Frontotemporal dementia (23)
Funding (900)
Gene editing (125)
Generative AI (9)
Gene therapy (311)
GLP-1 (287)
Government (940)
Grass and pollen (2)
Guidances (280)
Healthcare (9309)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (63)
Immunology and inflammation (98)
Immuno-oncology (55)
Indications (154)
Infectious disease (941)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (83)
Intellectual property (249)
Interviews (41)
IPO (12381)
IRA (2)
Job creations (1969)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (3)
Liver cancer (44)
Longevity (15)
Lung cancer (499)
Lymphoma (247)
Machine learning (27)
Management (3)
Manufacturing (519)
Marketing (7)
MASH (117)
Medical device (8648)
Medtech (8781)
Mergers & acquisitions (14368)
Metabolic disorders (695)
mRNA (50)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (217)
Neuropsychiatric disorders (38)
Neuroscience (1804)
NextGen: Class of 2026 (3150)
Non-profit (841)
Obesity (220)
Opinion (10)
Ovarian cancer (157)
Pain (170)
Pancreatic cancer (191)
Parkinson's disease (197)
Partnered (11)
Patents (461)
Patient recruitment (492)
Peanut (31)
People (41171)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15443)
Phase 2 (21343)
Phase 3 (14379)
Pipeline (6806)
Policy (18)
Postmarket research (1570)
Preclinical (6529)
Press Release (34)
Prostate cancer (188)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (562)
Real estate (3019)
Recruiting (6)
Regulatory (14745)
Reports (16)
Research institute (579)
Resumes & cover letters (45)
Rett syndrome (40)
RNA editing (5)
RSV (47)
Schizophrenia (99)
Series A (151)
Series B (119)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (87)
Sponsored (5)
Startups (2018)
Stomach cancer (3)
Supply chain (50)
Vaccines (315)
Venture capital (17)
Weight loss (72)
Women's health (76)
Date
Today (87)
Last 7 days (385)
Last 30 days (1264)
Last 365 days (19158)
2026 (11252)
2025 (19252)
2024 (22988)
2023 (26541)
2022 (34593)
2021 (37172)
2020 (33480)
2019 (23257)
2018 (17469)
2017 (18766)
2016 (17926)
2015 (24268)
2014 (21680)
2013 (18140)
2012 (20223)
2011 (20446)
2010 (20332)
Location
Africa (227)
Alabama (72)
Alaska (2)
Arizona (297)
Arkansas (11)
Asia (17861)
Australia (2092)
California (11646)
Canada (3070)
China (507)
Colorado (469)
Connecticut (399)
Delaware (205)
Europe (24613)
Florida (1743)
Georgia (367)
Hawaii (3)
Idaho (46)
Illinois (687)
India (45)
Indiana (310)
Iowa (14)
Japan (393)
Kansas (99)
Kentucky (30)
Louisiana (26)
Maine (25)
Maryland (1167)
Massachusetts (7680)
Michigan (301)
Minnesota (550)
Mississippi (4)
Missouri (79)
Montana (20)
Nebraska (11)
Nevada (112)
New Hampshire (60)
New Jersey (2569)
New Mexico (12)
New York (2760)
North Carolina (1242)
North Dakota (4)
Northern California (5809)
Ohio (271)
Oklahoma (14)
Oregon (16)
Pennsylvania (2215)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (75)
South Dakota (1)
Southern California (4833)
Tennessee (115)
Texas (1884)
United States (37935)
Utah (351)
Vermont (1)
Virginia (149)
Washington D.C. (38)
Washington State (906)
West Virginia (1)
Wisconsin (73)
483,656 Results for "aerogen inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
World-First Inhaled COVID-19 Vaccine, Developed in Partnership Between Aerogen® and CanSinoBIO, First Public Booster Immunization in China.
Late in 2021, Aerogen® and CanSinoBIO announced a development and commercial supply partnership for the inhaled delivery of CanSinoBIO’s Recombinant Novel Coronavirus Vaccine Convidecia Air™ utilizing Aerogen’s proprietary aerosol drug delivery technology.
November 14, 2022
·
7 min read
Drug Development
Aerogen® and CanSinoBIO agree on landmark development and commercial supply partnership for world’s first inhaled Covid-19 vaccine delivery
Following months of collaborative development work, Aerogen® and CanSinoBIO have announced a development and commercial supply partnership for the inhaled delivery of CanSinoBIO’s Recombinant Novel Coronavirus Vaccine Convidecia™ utilizing Aerogen’s proprietary vibrating mesh aerosol drug delivery technology.
December 9, 2021
·
5 min read
Aerogen Collaborates on Development of More Than 15 Potential COVID-19 Inhaled Therapies
Synairgen’s SNG001 among the many potential treatments and vaccines to be delivered via Aerogen’s aerosol drug delivery system Adds to the thousands of COVID-19 patients already safely and effectively treated with Aerogen’s Solo aerosol drug delivery system in the intensive care unit 1 Aerogen technology is featured in guidelines and papers on the treatment of COVID-19 patients across the globe 2 , 3 , 4
October 23, 2020
·
8 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Business
Aerogen Pharma Enters into Exclusive Agreements with Nuance Pharma to Advance Treatment of Respiratory Distress Syndrome in Premature Infants in China
Aerogen Pharma, and Nuance Pharma (“Nuance”), today announce an exclusive agreement to join forces in Greater China to develop a superior, non-invasive approach to treatment of RDS, a life-threatening condition of preterm infants associated with long-term lung health issues in survivors.
December 22, 2021
·
5 min read
Press Releases
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
July 29, 2026
·
6 min read
Press Releases
Therma Bright Inc. Completes Debt Settlements
July 30, 2026
·
3 min read
Aerogen Accelerates Global Growth with Temasek Investment
Aerogen today announced that Temasek, a global investment company headquartered in Singapore, has acquired a minority stake in Aerogen through the purchase of a secondary share interest. Financial terms of the transaction were not disclosed.
November 5, 2018
·
2 min read
Press Releases
Exagen Inc. Reports Second Quarter 2026 Financial Results
August 4, 2026
·
11 min read
Press Releases
Penumbra, Inc. Reports Second Quarter 2026 Financial Results
July 30, 2026
·
6 min read
1 of 48,366
Next
